Single Ascending Oral Dose Study of F901318

NCT02394483 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

F2G Ltd

Collaborators